Artikel ; Online: Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.
Current atherosclerosis reports
2011 Band 13, Heft 3, Seite(n) 277–284
Abstract: Decreased level of high density-lipoprotein cholesterol (HDL-C) is a rigorous predictor for future ... to the liver, improvement of endothelial function, and anti-inflammatory effects. Vascular imaging can aid ... wall inflammation. In this article we discuss these various imaging techniques and how they can assess ...
| Abstract | Decreased level of high density-lipoprotein cholesterol (HDL-C) is a rigorous predictor for future cardiovascular events. Much effort is being made to develop HDL-C-raising pharmacotherapies in the attempt to avert the pandemic of atherosclerotic disease. Important properties by which HDL-C-raising compounds are effective involve improvement of cholesterol uptake from macrophages in plaque for transport back to the liver, improvement of endothelial function, and anti-inflammatory effects. Vascular imaging can aid in the determination which HDL-C-raising compounds are effective. Ultrasound and MRI have proved suitable for assessment of structural changes of the vessel wall. Ultrasound can also be used or assessment of endothelial function. 18F-fluordeoxyglucose positron emission tomography has opened up the possibility to assess vessel wall inflammation. In this article we discuss these various imaging techniques and how they can assess efficacy as well as provide pathophysiologic information on the mechanism of action of novel HDL-C-raising drugs. |
|||||
|---|---|---|---|---|---|---|
| Mesh-Begriff(e) | Carotid Arteries/pathology ; Cholesterol, HDL/metabolism ; Drug Monitoring/methods ; Endothelium, Vascular/drug effects ; Endothelium, Vascular/metabolism ; Endothelium, Vascular/pathology ; Humans ; Hypolipidemic Agents/pharmacokinetics ; Hypolipidemic Agents/standards ; Hypolipidemic Agents/therapeutic use ; Lipid Metabolism/drug effects ; Magnetic Resonance Imaging ; Microscopy, Acoustic ; Pharmacology, Clinical/methods ; Plaque, Atherosclerotic/complications ; Plaque, Atherosclerotic/diagnosis ; Plaque, Atherosclerotic/drug therapy ; Plaque, Atherosclerotic/metabolism ; Positron-Emission Tomography ; Randomized Controlled Trials as Topic ; Tunica Intima/pathology ; Vasodilation/drug effects | |||||
| Chemische Substanzen | Cholesterol, HDL ; Hypolipidemic Agents | |||||
| Sprache | Englisch | |||||
| Erscheinungsdatum | 2011-04-05 | |||||
| Erscheinungsland | United States | |||||
| Dokumenttyp | Journal Article ; Review | |||||
| ZDB-ID | 2057369-8 | |||||
| ISSN | 1534-6242 ; 1523-3804 | |||||
| ISSN (online) | 1534-6242 | |||||
| ISSN | 1523-3804 | |||||
| DOI | 10.1007/s11883-011-0176-1 | |||||
| Signatur |
|
|||||
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 5534: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.